Skip to main content
OpenTrials

Clinical trial condition

Extensive-stage Small Cell Lung Cancer

Explore clinical trials studying Extensive-stage Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

26 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Extensive-stage Small Cell Lung Cancer trial results

Completed

A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer

NCT04702880

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small Cell Lung Cancer, +8 more
Locations
  • Local Institution - 0075 Birmingham, Alabama, United States
  • Local Institution - 0022 Hackensack, New Jersey, United States
  • Local Institution - 0002 Durham, North Carolina, United States
  • Local Institution - 0060 Cincinnati, Ohio, United States
View all 39 locations
View Trial Details
Completed

Study of Durvalumab in Combination With Platinum and Etoposide for the First Line Treatment of Patients With Extensive-stage Small Cell Lung Cancer

NCT04774380

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small Cell Lung Cancer, +8 more
Locations
  • Research Site Panagyurishte, Bulgaria
  • Research Site Rousse, Bulgaria
  • Research Site Sofia, Bulgaria
  • Research Site Sofia, Bulgaria
View all 35 locations
View Trial Details
Completed

Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer

NCT03913455

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small Cell Lung Cancer, +9 more
Locations
  • Indiana Univeristy Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • IU Health Ball Memorial Cancer Center Muncie, Indiana, United States
  • University of Virginia Health System Charlottesville, Virginia, United States
  • University of Wisconsin, Clinical Cancer Center Milwaukee, Wisconsin, United States
View Trial Details
Completed

Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy

NCT03911219

Conditions
Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +15 more
Locations
  • Onkologische Praxis im St. Marien-Krankenhaus Ahaus, Germany
  • Gesundheitszentrum St. Marien Amberg, Germany
  • Klinikum Arnsberg, Karolinen Hospital Arnsberg, Germany
  • MVZ am Klinikum Aschaffenburg Aschaffenburg, Germany
View all 92 locations
View Trial Details

Related conditions